Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG

SAR113244

Pharmaceutical form:solution for injection Route of administration: subcutaneous

DRUG

placebo

Pharmaceutical form:solution for injection Route of administration: subcutaneous

Trial Locations (1)

Investigational Site Number 276001, Berlin